NES
RCPI

New England Securities’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

New England Securities’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$0 Hold
40
– – ﹤0.01% 1787
2014
Q3 		$0 Hold
40
– – ﹤0.01% 1828
2014
Q2 		$1K Buy
+40
New +$694 ﹤0.01% 1693

Other funds holding RCPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Securities's RCPI Position: Q4 2014 in Review

New England Securities held its ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) position steady in Q4 2014 at 40 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

New England Securities first reported a position in RCPI in Q2 2014 and has held it in 3 quarters since. The position peaked at $1K in Q2 2014. 55 funds tracked by Wall St. Rank hold RCPI as of Q4 2014.

  • New England Securities held 40 shares of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) worth $0 as of Q4 2014.
  • New England Securities left its ROCK CREEK PHARMACEUTICALS INC COM STK (DE) share count unchanged in Q4 2014.
  • ROCK CREEK PHARMACEUTICALS INC COM STK (DE) made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1787 holding.
  • New England Securities first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and has held it in 3 quarters since.
  • New England Securities's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $1K in Q2 2014.
  • 55 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.